• Aglaris Ltd

    London; United Kingdom

    Aglaris is developing an automated cell culture bioreactor for the mass production of human stem cells. Aglaris Cell stems from the collaboration between researchers at two institutions, the biomaterials group at Barcelona’s IQS and the group for the Regulation of the Genetic Expression and Stability of Stem Cells at a leading organization.


  • Asgento

    Heidelberg; Germany


  • BioMediTech

    Tampere; Finland

    BioMediTech, a joint institute of Tampere University of Technology and University of Tampere, brings together a powerful mix of multidisciplinary expertise in life sciences and medical technology. Over 250 scientists conduct research and education in the fields of cell and molecular biology, genetics, biomaterials, biosensors, computational systems, biotechnology, biomedical engineering, and regenerative medicine.


  • Campania Bioscience Scarl

    Naples; Italy

    Campania Bioscience is a regional cluster set in Naples (Campania region – Southern Italy) gathering together competences and facilities in the fields of Health, Biotech and Agro-food, with the aim of valorising partners’ expertise in the value chain, stimulating exploitation of cluster assets, supporting knowledge transfer and encouraging international networking and partnerships.


  • China Bioengineering Technology Group Ltd

    Hong Kong

    China Bioengineering Technology Group Limited (CBT) is located in Hong Kong Science Park. It is a high-tech professional body comprising of biomedical science, precision medicine, as well as big data access, statistics and analysis. Our company possesses the independent intellectual property right for gene testing technology and platform for biomedical data analysis?including the patent for genetic testing and copyright for genetic testing software.


  • OnTarget Chemistry

    Uppsala; Sweden

    OnTarget Chemistry – was established, initially as OncoTargeting, in 2008 as a spin-out from the medicinal chemistry, combinatorial chemistry and preclinical analysis departments of Pharmacia (Biovitrum). We have continued to employ some of the industry’s most experienced chemists and run a well-trimmed organization with solid values of service, quality and efficiency.


  • OP2 Drugs SAS ("OP2")

    Pessac; France

    OP2 Drugs SAS ("OP2") is a biotech company that aims at developing innovative life-saving drugs for unmet medical needs, especially in the cardiology field. Our first patented compound, OP2113, which targets mitochondrial dysfunction, is in preclinical stage, with a strong scientific rational.


  • Redx Pharma

    Liverpool, United Kingdom

    Redx Pharma has quickly established itself as one of the largest biotechnology companies in Europe, focused on the development of a wide range of early stage, proprietary small molecule therapeutics to address high unmet medical needs in cancer and infectious disease. 


  • University of Birmingham

    Birmingham; United Kingdom

    Birmingham is constantly developing and evolving in its desire to become a leading global university. This is being achieved through the enhanced research power and reach; the distinctiveness of exceptional student experience; the breadth and depth of academic portfolio; size and extent of the global networks.


Membership - Join the Network!

Basic Membership for natural persons is free, while Advanced Membership for professionals including premium services costs only €100 p.a.
Click here to apply for network membership!


European Biotechnology Network AISBL

Rue de la Science 14b
1040 Brussels, Belgium

Tel: +32 2 588 70 71

Website Sponsor of the Month